{{Rsnum
|rsid=2612100
|Gene=TYMS
|Chromosome=18
|position=672363
|Orientation=plus
|GMAF=0.4949
|Gene_s=ENOSF1,TYMS
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 42.5 | 51.3
| HCB | 52.2 | 39.0 | 8.8
| JPT | 45.1 | 40.7 | 14.2
| YRI | 44.2 | 46.3 | 9.5
| ASW | 35.1 | 45.6 | 19.3
| CHB | 52.2 | 39.0 | 8.8
| CHD | 49.5 | 40.4 | 10.1
| GIH | 21.2 | 53.5 | 25.3
| LWK | 51.8 | 41.8 | 6.4
| MEX | 10.3 | 53.4 | 36.2
| MKK | 40.4 | 48.1 | 11.5
| TSI | 20.8 | 43.6 | 35.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=22964418
|Title=Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients
}}

{{on chip | Affy GenomeWide 6}}